Sept. 3, 2023
In August, AbbVie has secured European Commission (EC) approval for AQUIPTA® (atogepant) as a preventive treatment for adults experiencing four …
July 14, 2023
Since the early days of the pharmaceutical industry, small molecules have been the most extensively used group of drugs. Nowadays, …
June 20, 2023
Verge Genomics, a frontrunner in the implementation of AI in drug discovery, recently concluded the Phase 1 clinical trial of …
June 7, 2023
Incorporating AI in drug discovery is rapidly becoming a common practice in the pharmaceutical industry. The recent undertakings of UK-based …
May 31, 2023
In an essential leap forward for the utilization of artificial intelligence (AI) in drug discovery, Insilico Medicine secured Investigational New …
May 23, 2023
Valo Therapeutics Oy (ValoTx), a frontrunner in the development of advanced immunotherapies for cancer, has initiated its Phase I trial …
May 22, 2023
PharmEnable, an innovative drug discovery firm, recently secured $7.5M in Pre-Series A financing, reflecting growing confidence in its proprietary AI-based …
April 20, 2023
Myricx Pharma, an oncology drug discovery company specializing in precision medicines based on its N-myristoyltransferase (NMT) platform, has recently presented …
Feb. 4, 2023
Since a revolutionary discovery of penicillin in 1928 by Scottish bacteriologist and Nobel laureate Alexander Fleming, numerous inventions of new …
Oct. 18, 2022
Proteins are essential components of living matter — they function as building blocks for cells and tissues, as well as …
Aug. 30, 2022
Disclaimer: This post is not medical advice and is for informational purposes only. All the information contained here is related …
July 29, 2022
Lung cancer accounted for 18% of deaths caused by cancer in 2020, making it the leading cause of cancer mortality …
